Trials / Completed
CompletedNCT00941304
Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain
A Double-Blind, Double-Dummy, Placebo- and Active Controlled Evaluation of the Efficacy, Safety and Tolerability of Buprenorphine HCl Buccal Film in the Treatment of Pain Associated With Third Molar Extraction
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- BioDelivery Sciences International · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the activity of buprenorphine hydrochloride (HCl) buccal film in the treatment of dental pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | Single-dose of over-encapsulated oral 5-mg oxycodone capsule |
| DRUG | Buprenorphine | Single-dose of buprenorphine HCl buccal film |
| DRUG | Placebo Film | Single-dose of placebo buccal film |
| DRUG | Placebo Capsule | Single-dose of oral placebo capsule |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-07-17
- Last updated
- 2017-02-27
- Results posted
- 2016-02-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00941304. Inclusion in this directory is not an endorsement.